Holen Sie sich die Stockscreener-App
12.25
4.97%
-0.64
Handel nachbörslich:
12.25
Integra Lifesciences Holdings Corp Aktie (IART) Neueste Nachrichten
Integra Lifesciences (IART): Analyst Lowers Price Target to $25 | IART Stock News - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cable One, Inc. - GlobeNewswire Inc.
Integra LifeSciences stock target cut to $25 by JMP - Investing.com Nigeria
Integra LifeSciences (IART) Sees Lowered Price Target Amid Market Reaction | IART Stock News - GuruFocus
JPMorgan Chase & Co. Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - Defense World
Wells Fargo & Company Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - Defense World
U.S. Regenerative Artificial Skin Market 2025-2032: Top Trends - openPR.com
Integra LifeSciences (NASDAQ:IART) Shares Gap Down Following Weak Earnings - Defense World
Integra LifeSciences (IART) Faces Adjusted Price Target Amid Rev - GuruFocus
Integra LifeSciences (IART) Faces Adjusted Price Target Amid Revenue Concerns | IART Stock News - GuruFocus
Wells Fargo Lowers Price Target for Integra Lifesciences (IART) - GuruFocus
JP Morgan Adjusts Price Target for Integra Lifesciences (IART) | IART Stock News - GuruFocus
Wells Fargo Lowers Price Target for Integra Lifesciences (IART) | IART Stock News - GuruFocus
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2025 Earnings Call Transcript - Insider Monkey
Attention Long-Term Shareholders of Integra LifeSciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office is Inv - GlobeNewswire
Wells Fargo Adjusts Integra LifeSciences (IART) Price Target | I - GuruFocus
Raymond James Financial Inc. Makes New Investment in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra Lifesciences Holdings Corp (IART) Q1 2025 Earnings Call Highlights: Navigating ... - Yahoo Finance
Integra LifeSciences (IART) Reports Q1 2025 Results and Strategi - GuruFocus
Stock Hits Across The Board As Companies Adjust Expectations - Finimize
Integra Lifesciences Q1 2025 Earnings: Adjusted EPS of $0.41 Bea - GuruFocus
Integra LifeSciences (IART) Q1 Earnings: Misses EPS, Exceeds Rev - GuruFocus
Integra LifeSciences (IART) Reports Q1 Revenue Surpassing Expectations | IART Stock News - GuruFocus
Integra LifeSciences (IART) Reports Q1 2025 Results and Strategic Moves - GuruFocus
Integra: Q1 Earnings Snapshot - The Washington Post
Integra LifeSciences Q1 2025 Earnings Call Transcript - MarketBeat
Long-Term Shareholders Have Rights – If You Hold Akero - GlobeNewswire
Long-Term Shareholders Have Rights – If You Hold Akero Therapeutics, Inc. (NASDAQ: AKRO); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); or Virtu Financial Inc. (NASDAQ: VIRT), Contact Grabar La - TradingView
Earnings call transcript: Integra LifeSciences misses Q1 2025 targets, stock plunges - Investing.com
Integra Lifesciences Holdings Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Integra LifeSciences misses Q1 estimates, shares fall 4% - Investing.com
Integra LifeSciences Slashes FY25 Adj. EPS OutlookUpdate - Nasdaq
Integra Lifesciences Q1 2025 Earnings: Adjusted EPS of $0.41 Beats Estimates, Revenue Hits $382.7 Million - GuruFocus
Integra LifeSciences (IART) Q1 Earnings: Misses EPS, Exceeds Revenue Expectations - GuruFocus
Integra LifeSciences Reports First Quarter 2025 Financial Results - TradingView
Integra LifeSciences (NASDAQ:IART) Reports Q1 In Line With Expectations But Quarterly Revenue Guidance Significantly Misses Expectations - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Earnings To Watch: Integra Lifesciences Holdings Corp (IART) Rep - GuruFocus
Stock Performance Spotlight: Integra Lifesciences Holdings Corp (IART) Ends the Day at 16.44, Up by 0.31 - DWinneX
Is Integra Lifesciences Holdings Corp (IART) a good investment opportunity? - uspostnews.com
The Future of Integra Lifesciences Holdings Corp: Analyzing IART - investchronicle.com
An Analysis of Integra Lifesciences Holdings Corp (IART)’s Potential Price Growth - knoxdaily.com
Notice to Long-Term Shareholders of Integra Lifesciences Holdings Corporation (NASDAQ: IART); Methode Electronics, Inc. (NYSE: MEI); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investig - GlobeNewswire
Analysts Set Integra LifeSciences Holdings Co. (NASDAQ:IART) Target Price at $22.71 - Defense World
Integra Lifesciences Holdings Corp (NASDAQ:IART) Price Forecast For The Next 12 Months Is Set At 86. - Marketing Sentinel
Notice to Long-Term Shareholders of Integra Lifesciences - GlobeNewswire
Integra Lifesciences Holdings Corp (IART) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Sete News
IART Stock Sees Surge of Approximately 1.12% in Last Five Days - knoxdaily.com
Notice to Long-Term Shareholders of BioAge Labs, Inc. - GlobeNewswire
Post-Trade Analysis: Integra Lifesciences Holdings Corp (IART) Climbs 3.16, Closing at 15.67 - DWinneX
Integra LifeSciences stock hits 52-week low at $15.45 - Investing.com
JPMorgan Chase & Co. Purchases 113,061 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences to Release First Quarter 2025 Financial Results on May 5, 2025 - Nasdaq
Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025 - Yahoo Finance
Geode Capital Management LLC Sells 247,336 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Arrowstreet Capital Limited Partnership Has $312,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Truist Adjusts Price Target for Integra LifeSciences (IART) Ahea - GuruFocus
Integra LifeSciences (NASDAQ:IART) Stock Price Down 7.8% on Analyst Downgrade - Defense World
Integra LifeSciences stock hits 52-week low at $16.76 - Investing.com
Integra LifeSciences stock hits 52-week low at $16.76 By Investing.com - Investing.com Canada
0.11%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):